Clinical Trials Browser

Phase 1 × OTHER × tomivosertib × Clear all

NCT05744739 2025-10-21

Tomivosertib in Relapsed or Refractory Acute Myeloid Leukemia (AML)

Phase 1 Active not recruiting

Other hematologic neoplasm

Leukemia, Myeloid, Acute

NCT04261218 2022-07-20

Safety, Pharmacodynamics, Pharmacokinetics, and Efficacy of Tomivosertib Combined With Paclitaxel in Advanced Breast Cancer

Phase 1 Completed

Breast Neoplasms